CLPBY
Price
$9.21
Change
-$0.18 (-1.92%)
Updated
Jun 18 closing price
Capitalization
26.46B
60 days until earnings call
CNVVY
Price
$15.34
Change
-$0.31 (-1.98%)
Updated
Jun 18 closing price
Capitalization
5.48B
39 days until earnings call
Interact to see
Advertisement

CLPBY vs CNVVY

Header iconCLPBY vs CNVVY Comparison
Open Charts CLPBY vs CNVVYBanner chart's image
Coloplast AS
Price$9.21
Change-$0.18 (-1.92%)
Volume$185.52K
Capitalization26.46B
ConvaTec Group
Price$15.34
Change-$0.31 (-1.98%)
Volume$16.69K
Capitalization5.48B
CLPBY vs CNVVY Comparison Chart in %
Loading...
CLPBY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CNVVY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CLPBY vs. CNVVY commentary
Jun 21, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CLPBY is a Hold and CNVVY is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 21, 2025
Stock price -- (CLPBY: $9.21 vs. CNVVY: $15.34)
Brand notoriety: CLPBY and CNVVY are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: CLPBY: 89% vs. CNVVY: 71%
Market capitalization -- CLPBY: $26.46B vs. CNVVY: $5.48B
CLPBY [@Medical Specialties] is valued at $26.46B. CNVVY’s [@Medical Specialties] market capitalization is $5.48B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.56B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CLPBY’s FA Score shows that 1 FA rating(s) are green whileCNVVY’s FA Score has 1 green FA rating(s).

  • CLPBY’s FA Score: 1 green, 4 red.
  • CNVVY’s FA Score: 1 green, 4 red.
According to our system of comparison, CNVVY is a better buy in the long-term than CLPBY.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CLPBY’s TA Score shows that 5 TA indicator(s) are bullish while CNVVY’s TA Score has 4 bullish TA indicator(s).

  • CLPBY’s TA Score: 5 bullish, 3 bearish.
  • CNVVY’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, CLPBY is a better buy in the short-term than CNVVY.

Price Growth

CLPBY (@Medical Specialties) experienced а -5.60% price change this week, while CNVVY (@Medical Specialties) price change was -5.79% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -0.32%. For the same industry, the average monthly price growth was +1.36%, and the average quarterly price growth was +1.45%.

Reported Earning Dates

CLPBY is expected to report earnings on Aug 19, 2025.

CNVVY is expected to report earnings on Jul 29, 2025.

Industries' Descriptions

@Medical Specialties (-0.32% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CLPBY($26.5B) has a higher market cap than CNVVY($5.48B). CNVVY has higher P/E ratio than CLPBY: CNVVY (85.47) vs CLPBY (36.50). CNVVY YTD gains are higher at: 35.951 vs. CLPBY (-14.522). CLPBY has higher annual earnings (EBITDA): 7.65B vs. CNVVY (356M). CLPBY has higher revenues than CNVVY: CLPBY (24.1B) vs CNVVY (2.07B).
CLPBYCNVVYCLPBY / CNVVY
Capitalization26.5B5.48B483%
EBITDA7.65B356M2,148%
Gain YTD-14.52235.951-40%
P/E Ratio36.5085.4743%
Revenue24.1B2.07B1,163%
Total CashN/A42.6M-
Total DebtN/A1.3B-
FUNDAMENTALS RATINGS
CLPBY vs CNVVY: Fundamental Ratings
CLPBY
CNVVY
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
5
Undervalued
11
Undervalued
PROFIT vs RISK RATING
1..100
10036
SMR RATING
1..100
3591
PRICE GROWTH RATING
1..100
8043
P/E GROWTH RATING
1..100
7773
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CLPBY's Valuation (5) in the null industry is in the same range as CNVVY (11). This means that CLPBY’s stock grew similarly to CNVVY’s over the last 12 months.

CNVVY's Profit vs Risk Rating (36) in the null industry is somewhat better than the same rating for CLPBY (100). This means that CNVVY’s stock grew somewhat faster than CLPBY’s over the last 12 months.

CLPBY's SMR Rating (35) in the null industry is somewhat better than the same rating for CNVVY (91). This means that CLPBY’s stock grew somewhat faster than CNVVY’s over the last 12 months.

CNVVY's Price Growth Rating (43) in the null industry is somewhat better than the same rating for CLPBY (80). This means that CNVVY’s stock grew somewhat faster than CLPBY’s over the last 12 months.

CNVVY's P/E Growth Rating (73) in the null industry is in the same range as CLPBY (77). This means that CNVVY’s stock grew similarly to CLPBY’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CLPBYCNVVY
RSI
ODDS (%)
Bullish Trend 4 days ago
73%
Bearish Trend 3 days ago
45%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
59%
Bullish Trend 3 days ago
66%
Momentum
ODDS (%)
Bearish Trend 3 days ago
53%
Bearish Trend 3 days ago
48%
MACD
ODDS (%)
Bullish Trend 3 days ago
72%
Bearish Trend 3 days ago
44%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
58%
Bearish Trend 3 days ago
49%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
59%
Bullish Trend 3 days ago
50%
Advances
ODDS (%)
Bullish Trend 9 days ago
64%
Bullish Trend 16 days ago
60%
Declines
ODDS (%)
Bearish Trend 3 days ago
57%
Bearish Trend 3 days ago
52%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
59%
Bullish Trend 3 days ago
68%
Aroon
ODDS (%)
Bearish Trend 3 days ago
70%
Bullish Trend 3 days ago
53%
View a ticker or compare two or three
Interact to see
Advertisement
CLPBY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CNVVY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PGTRX67.930.30
+0.44%
Putnam Global Technology R
DNLDX59.860.17
+0.28%
BNY Mellon Active MidCap A
FEYAX27.590.04
+0.15%
Fidelity Advisor Asset Manager 85% A
LIAGX15.59N/A
N/A
Lord Abbett International Growth I
BSCMX17.20-0.05
-0.29%
Brandes Small Cap Value I

CLPBY and

Correlation & Price change

A.I.dvisor indicates that over the last year, CLPBY has been loosely correlated with CLPBF. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if CLPBY jumps, then CLPBF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CLPBY
1D Price
Change %
CLPBY100%
-1.92%
CLPBF - CLPBY
38%
Loosely correlated
-9.43%
SAUHY - CLPBY
34%
Loosely correlated
-1.71%
SMMNY - CLPBY
33%
Poorly correlated
-0.71%
SONVY - CLPBY
32%
Poorly correlated
+0.82%
ESLOY - CLPBY
32%
Poorly correlated
-1.75%
More

CNVVY and

Correlation & Price change

A.I.dvisor tells us that CNVVY and CRL have been poorly correlated (+26% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CNVVY and CRL's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CNVVY
1D Price
Change %
CNVVY100%
-1.95%
CRL - CNVVY
26%
Poorly correlated
+0.17%
TWST - CNVVY
26%
Poorly correlated
+5.81%
KIDS - CNVVY
24%
Poorly correlated
-1.08%
CLPBY - CNVVY
24%
Poorly correlated
-1.92%
CZMWY - CNVVY
23%
Poorly correlated
-1.27%
More